Download Drugs acting via ion channels and transporters

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Cytosol wikipedia , lookup

Endomembrane system wikipedia , lookup

Purinergic signalling wikipedia , lookup

List of types of proteins wikipedia , lookup

Chemical synapse wikipedia , lookup

Organ-on-a-chip wikipedia , lookup

Node of Ranvier wikipedia , lookup

Action potential wikipedia , lookup

NMDA receptor wikipedia , lookup

Cyclic nucleotide–gated ion channel wikipedia , lookup

Signal transduction wikipedia , lookup

Membrane potential wikipedia , lookup

Mechanosensitive channels wikipedia , lookup

Transcript
Mgr.Tereza Havlíčková
DRUGS ACTING VIA ION CHANNELS AND
TRANSPORTERS
ION CHANNELS

Voltage – gated channels

Activated by change of membrane voltage
Sodium
 Calcium
 Potassium


Ligand – gated channels

Extracelular ligands


GABA receptors, NMDA receptros, nicotin receptors
Intracelular ligands

ATP – K+- channels
ION CHANNELS
VOLTAGE – GATED CHANNELS

Calcium channels
 Smooth
muscles cells (L-channels)
 Vascular
smooth muscles
 Open by membrane depolarization
 Allows calcium input into muscle cell – contraction
 In therapy – calcium channel blockers
 Thalamic
 Calcium
neurons (T-channels)
input into brain cells inhibition
 Epilepsy therapy
CALCIUM CHANNEL (L-TYPE)
CALCIUM CHANNEL BLOCKERS
Drugs which blocks L-type of calcium channel
 Affects vascular smooth muscles and
myocardium
 Specifically bloks channel proteins – bloks
calcium input into cell – no contractions of
vascular muscles, slow contractions of heart

CALCIUM CHANNEL BLOCKERS

Kationic drugs
 Positive
charge
 Bind on channel protein, modulating heart action
 Verapamil, Diltiazem
 I – angina pectoris, tachycardia, hypertension
 Side effects – bradycardia, hypotension,
obstipation, headaches
CALCIUM CHANNEL BLOCKERS

Dihydropyridines
Nifedipine, isradipine, felodipine, amlodipine, lacidipine,
nitrendipine
 No charge on nitrogen
 No direct effect on heart
 Vasodilatation
 I – angina pectoris, hypertension
 Side effects – hypotension, reflex tachycardia
(prolonged forms, combination with beta-blockers)

CALCIUM CHANNELS BLOCKERS – T-TYPE

Brain neurons
Calcium input inhibition, inhibition of excitation
Some antiepileptics – etosuximid, valproate

Etosuximid – children state of absence


 Side
effects – nausea, vomit, tiredness, sleep
disorder

Valproate – wide activity, blocks natrium
channels too
VOLTAGE – GATED ION CHANNELS

Potassium channels


In heart – antidysrhytmic drugs
Sodium channels

Localization
Neurons and nerve endings (key channels for action potential
transmission)
 Myocardial cells
 Group of drugs which affects sodium channels




antidysrhytmic drugs
Local anesthetic drugs
Antiepileptic drugs
POTASSIUM CHANNELS INHIBITORS

Antidysrhytmic drugs
 Phase
of repolarization - output of K ions from the
cell
 Amiodaron
 Blocks
Ca and Na channels too
 Extends phase of repolarization
 Reduces heart rate
 Side effects – pulmonary fibrosis, skin pigmentation
SODIUM CHANNELS INHIBITORS

Antidysrhytmic drugs
 Fast
input of sodium into cell affects depolarization
– growth of action potential (AP)
 Lidocaine – effect during high frequency of AP
 Low
excitability, prolong phase of depolarization
 Tachycardias
 Also local anesthetic
 Chinidine
 Except

Na channels blocks K channels too
Atrial fibrillations
SODIUM CHANNELS INHIBITORS

Local anesthetics






Blocks sodium channels, thereby inhibit action potential
Vasodilator effect – vasoconstrictor addition
Hydrophobic substances with protonable nitrogen – can enter to cell
through membrane, than protonized – active substance blocks channel
During inflammation – changes of pH – changes of effect
Structure changes of cocaine molecule
Types of anesthesia – topical, infiltration, nerve – block anesthesia
and subarachnoid anesthesia

Important anesthetics – lidocaine, cinchocaine, mesocane,
tetracaine, procaine, articaine
SODIUM CHANNELS INHIBITORS

Antiepileptic drugs


Selective for hyperactive cells
Carbamazepine, oxcarbamazepine


Valproate


Blocks calcium channels too, affects also absences, inhibition of
transaminase, slower GABA degradation
Fenytoin



Grand-mal attacks
Antidysrhytmic use too
No effect against absences, just convulsions
Lamotrigine


Presynaptic sodium channels inhibition
On glutamatergic neurons – lower release of glutamate (excitation amino
acid)
LIGAND – GATED ION CHANNELS


Opening of channel is not acted by membrane
depolarization, but by binding of specific molecule to
channel receptor
Controlled by extracellular ligand




Nicotine muscular receptor
GABA receptor
NMDA receptor
Controlled by intracellular ligand

ATP controlled channel for potassium in B – cells of
pancreatic islands
NICOTINE RECEPTOR

Nicotine receptors in CNS (NN) and nicotine receptors
in neuromuscular junction (NM)


After occupation of receptor for acetylcholine (or similar
substance) is channel for sodium and potassium opened
Can be affected by myorelaxans

Depolarising


Atrakurium (tubocurarine like drugs)
Nondepolarising

Suxamethonium (acetylcholine like drugs)
MYORELAXANS
GABA RECEPTOR
BENZODIAZEPINES

Binding to binding space for benzodiazepines on GABA
receptor






Increase of affinity binding space for GABA
Increase of opening frequency of chloride channel – due to
input chlorides into cell is hyperpolarized membrane and
thereby lower excitability of cell
Effects – sedation, anxiolytic effect, central myorelaxation
Use – anxiety, insomnia, status epilepticus, premedication
before narcosis
Side effects – somnolence, confusion, loss of coordination
Overdose – flumazenil (competitive antagonist)
BENZODIAZEPINES
NMDA RECEPTOR
NMDA RECEPTOR
Receptor for excitatory amino acid glutamate –
non-specific channel for calcium, sodium and
potassium
 Inhibition by ketamine – injectable anesthetic

 Short-term
surgery, induction of anesthesia
 Blackout, low respiratory depression
 High
levels of ketamine - hallucinations
ATP RELATED POTASSIUM CHANNEL
Controlled by intracelular ligand
 B - cells of pancreatic islets (islets of
Langerhans)
 Channels are closed after binding of ATP (from
glycolysis) – membrane depolarization – insulin
release from vesicles

INSULIN SECRETAGOGUES
Blocks potassium channels – earlier
membrane depolarization and insulin release
 Patients with low stimulation of insulin
secretion (after food intake)
 Side effects – hypoglycaemia, weigh gain
 Important drugs – sulfonylureas
(glibenclamide, glipizide, glimepiride), glinides
(repaglinide, nateglinide)

TRANSPORT PROTEINS

„Pumps“
 Sodium
pump – Na+/K+ ATPase – transports
sodium and potassium ions against their
concentration gradient (heart...)
 Proton pump - H+/K+ ATPase – transports hydrogen
and potassium ions (gastric mucosa cells)
TRANSPORT PROTEINS

Specific transporters
 Permeates
the cell membrane and facilitates
transport of neuromediators
 Allows noradrenaline, serotonin and dopamine reuptake
 Allows right function, controls, how long
neuromediators remains in synapse
NA+/K+ ATPASE
Pump transports sodium ions from cell (against
their concentration gradient)
Cardiac glycosides
 Blocks active transport of sodium and
potassium ions – decrease of membrane
potential, accumulation of calcium in cell –
increase of cardiac muscle contraction force

CARDIAC GLYCOSIDES

Digoxin, digitoxin
 Originally
isolated from herb Digitalis Lanata or
Purpurea
 By binding to NA/K ATPase inhibits these ions
transport
 Narrow therapeutic range
 Changes
in potassium levels can affect their action
 In low levels is affinity to receptors higher – carefully
during diuretic therapy
PROTON PUMP
Localized on luminal side of gastric mucosa
 Transports hydrogen ions against their
concentration gradient to gastric fluid
 Increase of HCl production

PROTON PUMP
PROTON PUMP INHIBITORS
Drugs for gastric protection
 Intestinal absorption, blood transport to
parietal cell – activation
 Use on an empty stomach, half an hour before
meal (but meal is necessary to activation)
 Omeprazole, esomeprazole, pantoprazole

SPECIFIC TRANSPONTERS
Neuromediator re-uptake from the synapse
 Termination of mediator action, storage of
mediator into vesicles in neuronal ending
 Antidepressants

 Tricyclic
 Selective

re-uptake inhibitors
Other drugs effects to re-uptake
 Cocaine,
amphethamines
ANTIDEPRESSANTS

Depression
 Affective
disorder, mood disorder
 Monoamine theory – lack of neuromediators
 Therapy
– increase of neuromediators levels, prolong
their effects
 Symptoms
 Emotional
– depressive mood, reduction of interests
 Somatic – food intake reduction, insomnia, tiredness
ANTIDEPRESSANTS

Tricyclic drugs
 Older
group
 Increase levels of all monoamine(dopamine,
serotonin, noradrenaline)
 Re-uptake inhibition
 Effect after 2-4 weeks
 Imipramine, clomipramine, dosulepine, amitriptylin
ANTIDEPRESSANTS

Selective monoamine re-uptake inhibitors
 Serotonin
(SSRI)
 Effect
after 2-4 weeks
 Fluoxetine (Prozac), citalopram, sertraline (Zoloft),
escitalopram, paroxetine
 Serotonin
and noradrrenaline (SNRI)
 Venlafaxine,
duloxetine
 Noradrenaline and
 Bupropion
dopamine (NDRI)
– nicotin and other stimulant addiction
withdrawal symptoms
OTHER DRUGS EFFECTING RE-UPTAKE

Stimulant drugs
 Cocaine,
amphethamines
 Cocaine
blocks serotonin, dopamine and noradrenaline
re-uptake with same affinity
 Amphetamines block dopamine and noradrenaline reuptake with higher affinity, than serotonin re-uptake
 Amphethamines also block metabolism of monoamines
and increase monoamine release
THANK YOU FOR YOUR ATTENTION